- Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsisB Eisele
Clinical Research Department, Centeon Pharma GmbH, Marburg, Germany
Intensive Care Med 24:663-72. 1998..To evaluate the safety and potential efficacy of antithrombin III (AT III) in reducing mortality in patients with severe sepsis...